Member: $0.00
Non-Member: $19.99Your price



Please allow 2-3 minutes after your purchase for your course to be available in your AARC University classroom.

Preventing Respiratory Depression from Opioids [2026]


This session will explore the pathophysiology of respiratory depression due to opioid administration, identifying high-risk patients, and the respiratory therapist's role in patient monitoring and prevention of opioid-induced respiratory depression.

Successful completion of this course requires a score of 70% on the post-test.


This webcast is sponsored in part by an unrestricted educational grant from Covidien.

**Please note that all programs require the participant to view the entire program prior to taking the final quiz and obtaining a course certificate.**

Approved for 1.00 CRCE Hours.


SEMINAR OBJECTIVES

Discuss the pathophysiology of respiratory depression due to opioid administration
Identify high risk patients for respiratory depression due to opioid administration
Identify the respiratory therapist's role in patient monitoring and prevention of opioid-induced respiratory depression


CHAPTERS

Preventing Respiratory Depression from Opioids


Speaker Information

Lori Conklin, MD
Debbie Fox, MBA, RRT-NPS, FAARC